BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fülle L, Offermann N, Hansen JN, Breithausen B, Erazo AB, Schanz O, Radau L, Gondorf F, Knöpper K, Alferink J, Abdullah Z, Neumann H, Weighardt H, Henneberger C, Halle A, Förster I. CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons. Glia 2018;66:2246-61. [DOI: 10.1002/glia.23507] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Freff J, Bröker L, Leite Dantas R, Schwarte K, Bühlmeier J, Kraft I, Hinney A, Buhlmann U, Arolt V, Dannlowski U, Romer G, Baune BT, Hebebrand J, Föcker M, Alferink J. Expression of CXCR4 on CD4+ T cells predicts body composition parameters in female adolescents with anorexia nervosa. Front Psychiatry 2022;13:960905. [DOI: 10.3389/fpsyt.2022.960905] [Reference Citation Analysis]
2 Henning L, Antony H, Breuer A, Müller J, Seifert G, Audinat E, Singh P, Brosseron F, Heneka MT, Steinhäuser C, Bedner P. Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy. Glia. [DOI: 10.1002/glia.24265] [Reference Citation Analysis]
3 Zhang Y, Ye Y, Tang X, Wang H, Tanaka T, Tian R, Yang X, Wang L, Xiao Y, Hu X, Jin Y, Pang H, Du T, Liu H, Sun L, Xiao S, Dong R, Ferrucci L, Tian Z, Zhang S. CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure. J Exp Med 2022;219:e20200418. [PMID: 35687056 DOI: 10.1084/jem.20200418] [Reference Citation Analysis]
4 Zhang A, Liu Y, Xu H, Zhang Z, Wang X, Yuan L, Lenahan C, Zhang C, Jiang J, Fang C, Fang Y, Zhang J, Chen S. CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats. Stroke Vasc Neurol 2022:svn-2022-001659. [PMID: 35882433 DOI: 10.1136/svn-2022-001659] [Reference Citation Analysis]
5 Yilmaz C, Rogdakis T, Latorrata A, Thanou E, Karadima E, Papadimitriou E, Siapi E, Li KW, Katsila T, Calogeropoulou T, Charalampopoulos I, Alexaki VI. ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses. Biomolecules 2022;12:424. [DOI: 10.3390/biom12030424] [Reference Citation Analysis]
6 Asano H, Moriya S, Hatakeyama T, Kobayashi S, Akimoto T, Ohta R, Kawaguchi M. Possible effects of voluntary exercise intensity on anxiety-like behavior and its underlying molecular mechanisms in the hippocampus: Results from a study in Hatano rats. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113854] [Reference Citation Analysis]
7 Ye J, Wang H, Cui L, Chu S, Chen N. The progress of chemokines and chemokine receptors in autism spectrum disorders. Brain Res Bull 2021;174:268-80. [PMID: 34077795 DOI: 10.1016/j.brainresbull.2021.05.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Erazo AB, Wang N, Standke L, Semeniuk AD, Fülle L, Cengiz SC, Thiem M, Weighardt H, Strugnell RA, Förster I. CCL17-expressing dendritic cells in the intestine are preferentially infected by Salmonella but CCL17 plays a redundant role in systemic dissemination. Immun Inflamm Dis 2021;9:891-904. [PMID: 33945673 DOI: 10.1002/iid3.445] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Leite Dantas R, Freff J, Ambrée O, Beins EC, Forstner AJ, Dannlowski U, Baune BT, Scheu S, Alferink J. Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders? Cells 2021;10:941. [PMID: 33921690 DOI: 10.3390/cells10040941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Deng S, Jin P, Sherchan P, Liu S, Cui Y, Huang L, Zhang JH, Gong Y, Tang J. Recombinant CCL17-dependent CCR4 activation alleviates neuroinflammation and neuronal apoptosis through the PI3K/AKT/Foxo1 signaling pathway after ICH in mice. J Neuroinflammation 2021;18:62. [PMID: 33648537 DOI: 10.1186/s12974-021-02112-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
11 Flores-Aguilar L, Iulita MF, Kovecses O, Torres MD, Levi SM, Zhang Y, Askenazi M, Wisniewski T, Busciglio J, Cuello AC. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome. Brain 2020;143:3653-71. [PMID: 33206953 DOI: 10.1093/brain/awaa326] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 30.0] [Reference Citation Analysis]
12 Mesquida-Veny F, Del Río JA, Hervera A. Macrophagic and microglial complexity after neuronal injury. Prog Neurobiol 2021;200:101970. [PMID: 33358752 DOI: 10.1016/j.pneurobio.2020.101970] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
13 Deng S, Sherchan P, Jin P, Huang L, Travis Z, Zhang JH, Gong Y, Tang J. Recombinant CCL17 Enhances Hematoma Resolution and Activation of CCR4/ERK/Nrf2/CD163 Signaling Pathway After Intracerebral Hemorrhage in Mice. Neurotherapeutics 2020;17:1940-53. [PMID: 32783091 DOI: 10.1007/s13311-020-00908-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
14 Bogacka J, Ciapała K, Pawlik K, Dobrogowski J, Przeklasa-Muszynska A, Mika J. Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia - Evidence from a Mouse Model of Diabetic Neuropathy. Neuroscience 2020;441:77-92. [PMID: 32592824 DOI: 10.1016/j.neuroscience.2020.06.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bogacka J, Ciapała K, Pawlik K, Kwiatkowski K, Dobrogowski J, Przeklasa-Muszynska A, Mika J. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain. Front Immunol 2020;11:1241. [PMID: 32760393 DOI: 10.3389/fimmu.2020.01241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Bogacka J, Popiolek-Barczyk K, Pawlik K, Ciechanowska A, Makuch W, Rojewska E, Dobrogowski J, Przeklasa-Muszynska A, Mika J. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain. Eur J Pharmacol 2020;880:173166. [PMID: 32407723 DOI: 10.1016/j.ejphar.2020.173166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sundaramoorthy V, Godde N, Farr RJ, Green D, Haynes JM, Bingham J, O'Brien CM, Dearnley M. Modelling Lyssavirus Infections in Human Stem Cell-Derived Neural Cultures. Viruses 2020;12:E359. [PMID: 32218146 DOI: 10.3390/v12040359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M, Keinänen J, Mäntylä T, Paju J, Ilonen T, Armio RL, Walta M, Tuisku J, Helin S, Marjamäki P, Hovatta I, Therman S, Vaarala O, Linnaranta O, Kieseppä T, Salokangas RKR, Honkanen J, Hietala J, Suvisaari J. Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Transl Psychiatry 2020;10:94. [PMID: 32179746 DOI: 10.1038/s41398-020-0776-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]